Zai Lab Pays $15 Million for China Rights to Electric Field Therapy for Brain Cancer Sep 13, 2018 Life Science
Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders Sep 12, 2018 Life Science
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer Sep 11, 2018 Life Science
Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal Sep 11, 2018 Life Science
Miracor Medical closes final tranche of Series-D, bringing the round to €30M Sep 5, 2018 Life Science
